Clinical Trials Logo

Migraine clinical trials

View clinical trials related to Migraine.

Filter by:

NCT ID: NCT04100135 Active, not recruiting - Migraine Clinical Trials

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study

RELIEF
Start date: February 5, 2021
Phase: N/A
Study type: Interventional

Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief

NCT ID: NCT03867201 Active, not recruiting - Migraine Clinical Trials

Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients

DRAGON
Start date: August 26, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of erenumab in patients with chronic migraine in Asian population.

NCT ID: NCT03727672 Active, not recruiting - Migraine Clinical Trials

Salivary Inflammatory Markers in Tension Type Headache and Migraine

SalHead
Start date: January 1, 2016
Phase:
Study type: Observational

Data role of salivary inflammatory markers in migraine and Tension Type headache (TTH) are lacking. Τhe investigators studied whether headache attacks are associated with changes in C reactive protein (CRP), Interleukin -1β and Interleukin -6 in saliva in patients with Tension Type Headache and Migraine and age matched healthy controls . Τhe investigators, also investigated whether these markers could be influenced by comorbidities such as depression and anxiety.

NCT ID: NCT03511846 Active, not recruiting - Migraine Clinical Trials

Pain Biomarker Study

PBS
Start date: March 21, 2018
Phase: Phase 1
Study type: Interventional

This study investigates molecular and physical biomarkers of headaches in order to better understand mechanisms of these diseases. There are 3 main parts: 1. Use of capsaicin (active ingredient in hot chili peppers) to trigger release of calcitonin gene related peptide - the hypothesis is that this will be different in headache subjects compared to controls (and if so might be used to predict how these patients will respond to certain medications that modulate calcitonin gene-related peptide). Subjects will be given capsaicin as a cream applied to the forehead or the inner nostril, or a hot sauce that is ingested. 2. Use of capsaicin to trigger eye watering - the hypothesis is that oxygen gas will slow down the amount of eye watering. Cluster headache patients respond very powerfully to oxygen gas but to very little else. The mechanism for oxygen is unknown but in rodents there is data that it works on the parasympathetic / lacrimal gland system. This study translates rodent data into humans in a non-invasive way to confirm the mechanism of this very effective treatment. 3. Use of ice water to trigger headaches - brain freeze causes a very short-lived but intense headache that may cause similar biomarker release as other headache disorders. This may be a useful human model for other headache disorders.

NCT ID: NCT03494673 Active, not recruiting - Migraine Clinical Trials

Prediction of WMH in Migraine Using a BOLD-CVR Map

Start date: July 13, 2018
Phase:
Study type: Observational

Brain white matter hyperintensities (WMHs) are prevalent in migraineurs, of which the mechanism is still unclear. The investigators aimed to test the spatial association between areas with reduced cerebrovascular reactivity (CVR) to hypercapnic stimuli and consequent development of WMHs.

NCT ID: NCT03487978 Active, not recruiting - Migraine Clinical Trials

Longitudinal Changes of Brain Functional Connectivity in Migraine

Start date: July 24, 2017
Phase:
Study type: Observational

The purpose of this study is to identify a core fMRI feature that determines migrainous brain and plastic fMRI features that changes with longitudinal courses of migraine.

NCT ID: NCT03301441 Active, not recruiting - Ischemic Stroke Clinical Trials

Sensitivity to Acute Cerebral Ischemia in Migrainers

SAMCO-MIG
Start date: February 9, 2018
Phase:
Study type: Observational

Sensitivity to Acute Middle cerebral or intracranial Carotid artery Occlusion in MIGrainers (SMCO-MIG) is a prospective multi-center study to determine if migraine induces a faster infarct growth as assessed by initial multimodal imaging.

NCT ID: NCT03081390 Active, not recruiting - Migraine Clinical Trials

Migraine and CVD Risk in Women

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The primary goal of this study is to test the effects of a high-fat, high-carbohydrate mixed meal on candidate modulators of cardiovascular disease risk (inflammation, vascular reactivity, sympathetic nervous system tone, and response to pain) in young adult women with migraine compared with healthy young women. This is study enrolling both cases (women with migraine) and controls (women without migraine), with equal numbers of normal weight and obese women in each group. Participants will undergo a telephone screening and a single day in-person study visit.

NCT ID: NCT02954276 Active, not recruiting - Migraine Clinical Trials

Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers

Start date: March 2016
Phase: Phase 1
Study type: Interventional

the trial is a randomized, open label, crossover, single-administration bioavailability study to compare the pharmacokinetic parameters of Omexa sumatriptan transmucosal sublingual tablet versus commercial Imitrex® sumatriptan oral tablet in 14 healthy volunteers.

NCT ID: NCT00285402 Active, not recruiting - Migraine Clinical Trials

Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine

Start date: May 2007
Phase: Phase 2
Study type: Interventional

The purpose of this migraine prevention study is to evaluate the efficacy and safety of AST-726 in moderate to severe migraine patients at one of two doses compared to placebo and compared to a baseline period as measured by a reduction in the number of migraine days.